![Robert F. Roscigno](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert F. Roscigno
President bij Robert F. Roscigno Phd Consulting LLC
Profiel
Robert F.
Roscigno currently works at Robert F.
Roscigno Phd Consulting LLC, as President.
Dr. Roscigno also formerly worked at United Therapeutics Corp., as Director & Senior VP-Commercial Development, Liquidia Technologies, Inc., as Senior Vice President-Product Development from 2017 to 2020, Vero Biotech LLC, as Executive Vice President-Global Clinical Affairs from 2013 to 2015, and Lung Biotechnology PBC, as President & Chief Operating Officer from 2005 to 2007.
Dr. Roscigno received his doctorate degree from Duke University and undergraduate degree from Trinity College (Connecticut).
Actieve functies van Robert F. Roscigno
Bedrijven | Functie | Begin |
---|---|---|
Robert F. Roscigno Phd Consulting LLC | President | - |
Eerdere bekende functies van Robert F. Roscigno
Bedrijven | Functie | Einde |
---|---|---|
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Corporate Officer/Principal | 01-07-2020 |
Vero Biotech LLC
![]() Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Corporate Officer/Principal | 01-09-2015 |
Lung Biotechnology PBC
![]() Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Lung Biotechnology PBC develops pharmaceutical products. It specializes in clinical trials, lung perfusion, and XenoLung. The company was founded by Martine Rothblatt and is headquartered in Silver Spring, MD. | President | 01-07-2007 |
UNITED THERAPEUTICS CORPORATION | Directeur/Bestuurslid | - |
Opleiding van Robert F. Roscigno
Duke University | Doctorate Degree |
Trinity College (Connecticut) | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
UNITED THERAPEUTICS CORPORATION | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
Vero Biotech LLC
![]() Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Health Technology |
Lung Biotechnology PBC
![]() Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Lung Biotechnology PBC develops pharmaceutical products. It specializes in clinical trials, lung perfusion, and XenoLung. The company was founded by Martine Rothblatt and is headquartered in Silver Spring, MD. | Health Technology |
Robert F. Roscigno Phd Consulting LLC |